Monteris Medical secures $28 million in Series E funding to accelerate growth in minimally invasive neurosurgery, led by InnovaHealth Partners and Birchview Capital.
InnovaHealth PartnersOsf VenturesColorado University Healthcare Innovation FundMadryn Asset Management, LPInnova Health PartnersBirchview Capital, LP
Description
Monteris Medical has closed $28 million in Series E equity financing to support its technology innovation program and growth initiatives. The funding will help expand the company's U.S. commercial footprint and accelerate advancements in clinical research. Notable investors include InnovaHealth Partners and Birchview Capital, along with new participants OSF Ventures and the Colorado University Healthcare Innovation Fund.
Company Information
Company
Monteris Medical
Location
131 Cheshire Lane
Minnetonka, Minnesota, United States
About
Monteris Medical is a privately held company that develops and markets innovative MR-guided ablation systems to perform minimally invasive, robotically controlled brain surgery, commonly referred to as laser ablation, LITT (Laser Interstitial Thermal Therapy) or SLA (Stereotactic Laser Ablation). The Monteris NeuroBlate System is the only minimally invasive system that enables a robotic interface for the precise and safe delivery of laser energy. The Monteris Medical NeuroBlate System is a neurosurgical tool and is intended for ablating intracranial soft tissue, including brain structures such as brain tumors, radiation necrosis, and epileptic foci (as identified by non-invasive and invasive neurodiagnostic testing, including imaging). For more information, visit monteris.com.
Fundz sees it the moment Monteris Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MinnetonkaManufacturingBiotechnologyHealthcareHealth CareMedicalMedical Device